Find Denotivir manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Wratizolin, 51287-57-1, Itcl, Denotivir [inn], Vratizolin, Polvir
Molecular Formula
C18H14ClN3O2S
Molecular Weight
371.8  g/mol
InChI Key
ZPBLNADJHWHOEP-UHFFFAOYSA-N
FDA UNII
W656S9I00W

Denotivir
Denotivir is an isothiazole derivative of 5-amino-3-methylisothiazolocarboxylic acid I with antiviral activity against human herpes simplex viruse types 1 and 2, and varicella zoster virus.
1 2D Structure

Denotivir

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-benzamido-N-(4-chlorophenyl)-3-methyl-1,2-thiazole-4-carboxamide
2.1.2 InChI
InChI=1S/C18H14ClN3O2S/c1-11-15(17(24)20-14-9-7-13(19)8-10-14)18(25-22-11)21-16(23)12-5-3-2-4-6-12/h2-10H,1H3,(H,20,24)(H,21,23)
2.1.3 InChI Key
ZPBLNADJHWHOEP-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=NSC(=C1C(=O)NC2=CC=C(C=C2)Cl)NC(=O)C3=CC=CC=C3
2.2 Other Identifiers
2.2.1 UNII
W656S9I00W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-(benzoylamino)-n-(4-chlorophenyl)-3-methyl-4-isothiazolecarboxamide

2. Bacpmi

3. Itcl

4. Wratizolin

2.3.2 Depositor-Supplied Synonyms

1. Wratizolin

2. 51287-57-1

3. Itcl

4. Denotivir [inn]

5. Vratizolin

6. Polvir

7. Vratizolin; Wratizolin

8. 5-benzamido-n-(4-chlorophenyl)-3-methyl-1,2-thiazole-4-carboxamide

9. Denotivir (inn)

10. W656s9i00w

11. 5-benzamido-4'-chloro-3-methyl-4-isothiazolecarboxanilide

12. 5-(benzoylamino)-n-(4-chlorophenyl)-3-methyl-4-isothiazolecarboxamide

13. 5-benzamido-n-(4-chlorophenyl)-3-methylisothiazole-4-carboxamide

14. Vratizolinum

15. T-15

16. Unii-w656s9i00w

17. P-chlorophenylamide Of 3-methyl-5-benzoylaminoizothiazole-4-carboxylic Acid

18. Polvir (tn)

19. 3-methyl-5-benzoylaminoisothiazole-4-carboxylic Acid P-chlorophenylamide

20. 5-(benzoylamino)-n-(p-chlorophenyl)-3-methyl-4-isothiazolecarboxamide

21. Denotivir [mart.]

22. Denotivir [who-dd]

23. Schembl147338

24. Chembl2104203

25. Dtxsid70199278

26. Zinc608304

27. Stl450987

28. 4-isothiazolecarboxamide, 5-(benzoylamino)-n-(p-chlorophenyl)-3-methyl-

29. Ft-0755612

30. D07789

31. Q11693881

32. N-(4-chlorophenyl)-3-methyl-5-[(phenylcarbonyl)amino]-1,2-thiazole-4-carboxamide

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 371.8 g/mol
Molecular Formula C18H14ClN3O2S
XLogP34.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass371.0495256 g/mol
Monoisotopic Mass371.0495256 g/mol
Topological Polar Surface Area99.3 Ų
Heavy Atom Count25
Formal Charge0
Complexity479
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty